The study, published in the journal Anesthesiology, found that in a group of 1,005 vascular surgery patients, symptomatic and asymptomatic LV dysfunction was associated with cardiovascular events, including myocardial infarction, and cardiovascular-related death 30 days following surgery.
Researchers recommended evaluation for all possible cardiovascular risk factors in high risk surgery patients and recommended perioperative therapy such as beta-blockers to improve outcomes.
Read the ASA’s release about cardiovascular risk in surgery.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.